<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
CALYPTE BIOMEDICAL CORPORATION
- -------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 06-1226727
- -------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
1440 Fourth Street, Berkeley, California 94710
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
None
- -------------------------------------------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.001 par value per share
- -------------------------------------------------------------------------------
(Title of Class)
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered
Incorporated by reference to pages 44 and 45 of the
Preliminary Prospectus contained in Registrant's Registration
Statement on Form S-1 filed with the Securities and Exchange
Commission on May 20, 1996 (Commission File No. 333-04105) and
to pages 46 and 47 of Amendment No. 1 to the Registration
Statement on Form S-1 filed with the Securities and Exchange
Commission on June 25, 1996 (collectively, the "Registration
Statement").
Item 2. Exhibits
The following exhibits are filed as a part of this
registration:
1. Form of specimen certificate for Registrant's Common
Stock.*
2. Restated Certificate of Incorporation of Registrant.**
3. Bylaws of Registrant.***
- ---------------
* Incorporated by reference to Exhibit 4.1 to the Registration Statement.
** Incorporated by reference to Exhibits 3.1 and 3.2 to the Registration
Statement.
*** Incorporated by reference to Exhibit 3.3 to the Registration Statement.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.
Date: July 10, 1996 Calypte Biomedical Corporation
By: /s/ JOHN P. DAVIS
-----------------------------------------
John P. Davis
President and Chief Executive Officer
<PAGE> 3
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Page Number
------------
<S> <C> <C>
1. Specimen Stock Certificate Incorporated
by Reference
2. Restated Certificate of Incorporation Incorporated
by Reference
3. Bylaws Incorporated
by Reference
</TABLE>
